Understanding Myeloma | How You Can Collaborate in Your Care from Patient Empowerment Network on Vimeo. This animated video reviews the types of myeloma, essential testing following a myeloma diagnosis, and advice for working with your healthcare team for the best overall care. See More from Collaborate Myeloma Related Resources: Collaborate | Being an Empowered Myeloma Patient  Myeloma Support and Resources | Why It’s Essential to Voice Your Concerns  The Benefits of Shared Decision-Making for Myeloma Care  Transcript: Bianca:  Welcome back! I’m Bianca, and I ..read more

Dr. Eugene Manley: Why Is It Important for You to Empower Patients? from Patient Empowerment Network on Vimeo. Drawing from his experiences interacting with patients, survivors, and caregivers, Dr. Eugene Manley emphasizes the significance of providers meeting patients “where they are” emotionally, mentally, and logistically. See More from Empowering Providers to Empower Patients (EPEP) Related Resources: Dr. Joshua Sabari: Why Is It Important for You to Empower Patients? Dr. Samuel Cykert: Why Is It Important for You to Empower Patients? Dr. Charlotte Gamble: Why Is It Important fo ..read more

Dr. Joshua Sabari: Why Is It Important for You to Empower Patients? from Patient Empowerment Network on Vimeo. Dr. Joshua Sabari emphasizes the importance of active listening and non-judgmental communication in patient care. Dr. Sabari shares how allowing patients to express themselves fully and addressing all their concerns without interruption fosters trust and empowerment. See More from Empowering Providers to Empower Patients (EPEP) Related Resources: Dr. Eugene Manley: Why Is It Important for You to Empower Patients? Dr. Samuel Cykert: Why Is It Important for You to Empower Patie ..read more

How Can We Leverage Lung Cancer Biomarker Data to Address Health Disparities? from Patient Empowerment Network on Vimeo. How can biomarker disparities be overcome by data collection? Experts Dr. Joshua Sabari from NYU Langone and Dr. Eugene Manley from SCHEQ Foundation discuss the status of biomarker data sharing, biobanks, and improvements that can be made toward the future. Download Resource Guide  | Descargar guía de recursos See More from [ACT]IVATED NSCLC Biomarkers Related Resources: Hope Unleashed: Advancing Therapies for Defiant Mutations in Lung Cancer Maximizing Biomarker ..read more

Maximizing Biomarker Equity: Leveraging Partnerships to Close Biomarker Disparities in Lung Cancer from Patient Empowerment Network on Vimeo. How can biomarker disparities be minimized by lung cancer partnerships? Expert Dr. Eugene Manley from SCHEQ Foundation discusses individuals, lung cancer partnerships, and how partners can work collaboratively toward improved biomarker disparities and health outcomes. Download Resource Guide  | Descargar guía de recursos See More from [ACT]IVATED NSCLC Biomarkers Related Resources: Hope Unleashed: Advancing Therapies for Defiant Mutations in Lu ..read more

Hope Unleashed: Advancing Therapies for Defiant Mutations in Lung Cancer from Patient Empowerment Network on Vimeo. What promising studies in lung cancer mutations are there that patients should know about? Expert Dr. Joshua Sabari from NYU Langone discusses common lung cancer mutations, incidence rates, promising and potential studies, and proactive patient advice. [ACT]IVATION TIP “…no matter what your lung cancer type is, no matter any clinical characteristic, you need next generation sequencing done, biomarker testing done, to identify these mutations. And even when we identify the mutat ..read more

Equity in Action: Addressing Biomarker Disparities in Lung Cancer from Patient Empowerment Network on Vimeo. How can biomarker disparities be reduced in lung cancer patients? Experts Dr. Joshua Sabari from NYU Langone and Dr. Eugene Manley from SCHEQ Foundation discuss approaches that are being used for community engagement and further interventions that can be used to reduce disparities. Download Resource Guide  | Descargar guía de recursos See More from [ACT]IVATED NSCLC Biomarkers Related Resources: Understanding Non-Small Cell Lung Cancer: Types, Biomarkers, and Treatment Insight ..read more

When Should Lung Cancer Patients Receive Biomarker Testing? from Patient Empowerment Network on Vimeo. Biomarker testing is vital for non-small cell lung cancer (NSCLC) patients, but when should it happen? Expert Dr. Joshua Sabari from NYU Langone discusses cancer cell mutations and ideal timing for biomarker testing for the best patient care. Download Resource Guide  | Descargar guía de recursos See More from [ACT]IVATED NSCLC Biomarkers Related Resources: Understanding Non-Small Cell Lung Cancer: Types, Biomarkers, and Treatment Insights Navigating Lung Cancer Biomarker Testing ..read more

Understanding Non-Small Cell Lung Cancer: Types, Biomarkers, and Treatment Insights from Patient Empowerment Network on Vimeo. How can non-small cell lung cancer (NSCLC) patients be empowered when newly diagnosed? Expert Dr. Joshua Sabari from NYU Langone discusses what he shares about NSCLC incidence rates, histology, and biomarkers with patients and families. [ACT]IVATION TIP “…know what type of cancer you have, the histology. Whether it be adenocarcinoma or squamous cancer. And equally as important, know your biomarker, what mutation is driving your cancer and what PD-L1 expression your t ..read more

Descargar guía de recursos Spanish ACTIVATED NSCLC Biomarkers Resource Guide_Drs. Sabari and Manley Download Resource Guide  | Descargar guía de recursos See More from [ACT]IVATED NSCLC Biomarkers The post [ACT]IVATED NSCLC Biomarkers Resource Guide II en español appeared first on Patient Empowerment Network ..read more